Who owns CONNECT BIOPHARMA HLDGS LTD?
- Ticker: CNTB
- CUSIP Number: g23549101
Tip: Access positions for across all investors
Analyze quarterly positions in Connect Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Connect Biopharma Hldgs stock
Who bought or sold CONNECT BIOPHARMA HLDGS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 5.5M | $14M | 12% | Mar 2026 |
|
| Boothbay Fund Management | 1.3M | $3.3M | 0% | Mar 2026 |
|
| 683 Capital Management | 900k | $2.4M | 100% | Mar 2026 |
|
| Perceptive Advisors | 793k | $2.1M | 0% | Mar 2026 |
|
| ADAR1 Capital Management | 742k | $1.9M | 100% | Mar 2026 |
|
| Richmond Brothers | 477k | $1.2M | 175% | Mar 2026 |
|
| Millennium Management | 475k | $1.2M | 909% | Mar 2026 |
|
| BML Capital Management | 409k | $1.1M | 0% | Mar 2026 |
|
| Knott David M Jr | 388k | $1.0M | 94% | Mar 2026 |
|
| Susquehanna International | 324k | $849k | 353% | Mar 2026 |
|
| Stonepine Capital Management | 310k | $812k | 100% | Mar 2026 |
|
| Propel Bio Management | 210k | $554k | 100% | Mar 2026 |
|
| Diadema Partners | 201k | $526k | 100% | Mar 2026 |
|
| Burkehill Global Management | 150k | $360k | 100% | Mar 2026 |
|
| Renaissance Technologies | 121k | $316k | -16% | Mar 2026 |
|
| Citadel Advisors | 113k | $295k | 13% | Mar 2026 |
|
| Marshall Wace | 66k | $173k | -49% | Mar 2026 |
|
| Jane Street | 52k | $136k | -37% | Mar 2026 |
|
| Simplify Asset Management | 52k | $135k | 100% | Mar 2026 |
|
| Persistent Asset Partners | 51k | $133k | 90% | Mar 2026 |
|
| Koa Wealth Management | 50k | $130k | 0% | Mar 2026 |
|
| Two Sigma Investments | 48k | $124k | 100% | Mar 2026 |
|
| Fifth Lane Capital | 45k | $118k | 100% | Mar 2026 |
|
| XTX Topco | 41k | $108k | 100% | Mar 2026 |
|
| Royal Bank of Canada | 40k | $106k | 100% | Mar 2026 |
|
| Geode Capital Management | 32k | $84k | 38% | Mar 2026 |
|
| Goldman Sachs Group | 30k | $78k | 100% | Mar 2026 |
|
| Point72 Asset Management | 20k | $52k | 20% | Mar 2026 |
|
| Virtu Financial | 17k | $44k | 100% | Mar 2026 |
|
| Bank of America Corporation | 16k | $41k | 100% | Mar 2026 |
|
| Hrt Financial | 15k | $40k | -9% | Mar 2026 |
|
| SmartHarvest Portfolios | 13k | $34k | 100% | Mar 2026 |
|
| Monograph Wealth Advisors | 11k | $29k | 0% | Mar 2026 |
|
| FNY Investment Advisers | 5.0k | $11k | 0% | Jun 2026 |
|
| Morgan Stanley | 3.6k | $9.4k | 63% | Mar 2026 |
|
| Rhumbline Advisers | 780.00 | $2.0k | 0% | Mar 2026 |
|
| UBS Group | 33.00 | $86.001300 | -99% | Mar 2026 |
|
| SBI Securities | 6.00 | $16.000200 | 0% | Mar 2026 |
|
| Citigroup | 1.00 | $3.000000 | 100% | Mar 2026 |
|
Who sold out of Connect Biopharma Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| OMERS Administration Corporation | Dec 2025 | 81k | $228k |
| Qube Research & Technologies | Dec 2025 | 10k | $30k |
| Simplex Trading | Dec 2025 | 98.00 | $275.997400 |